Related case:
UKAD 2022 UKAD vs Rowland Kaye
January 4, 2023
In March 2022 the United Kingdom Anti-Doping (UKAD) reported an anti-doping rule violation against the rugby player Rowland Kaye after his A and B samples tested positive for metabolites of the prohibited substance Methasterone and/or Oxymetholone in a low concentration.
Consequently the National Anti-Doping Panel decided on 4 January 2023 to impose a 4 year period of ineligibility on the Athlete. The Panel ruled that the Athlete is not a cheat, yet he acted negligently with his supplements and he could not identify the source of the metabolites found in his samples.
Hereafter in January 2023 the Athlete appealed this Decision with the National Anti-Doping Appeal Tribunal. He requested the Appeal Panel to set aside the Appealed Decision and to impose a reduced sanction.
The Athlete admitted the violation and denied the intentional use of the substances. He acknowledged that he could not demonstrate how the metabolites came into his system.
The Appeal Panel assessed and addressed the Athlete's assertions and evidence in this case and determines that he failed to discharge the burden of proof that the anti-doping rule violation was not intentional. The Panel agrees that the Athlete is not a cheat, yet he failed to demonstrate with the filed evidence that he did not have the requisite intention.
Therefore the National Anti-Doping Appeal Tribunal decides on 26 April 2023 to dismiss the Athlete's appeal and to uphold the Appealed Decision of 4 January 2023.